publicações selecionadas
- Expression profiles of gastric cancer molecular subtypes in remnant tumors
- Multivisceral resection compared to standard gastrectomy for gastricadenocarcinoma:Apropensity score‐matchinganalysis
- Preoperative chemotherapy is a better strategy than upfront surgery in cT4 gastric cancer
- Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Western Center Case Series
- THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY
- 628: SHORT-TERM SURGICAL OUTCOMES OF ROBOTIC GASTRECTOMY COMPARED TO OPEN GASTRECTOMY FOR PATIENTS WITH GASTRIC CANCER: A RANDOMIZED TRIAL
- Remnant gastric cancer: An ordinary primary adenocarcinoma or a tumor with its own pattern?
- 913 EPSTEIN-BARR TUMOR-ASSOCIATED INFECTION IS RESTRICTED TO MORE DISTAL ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION (AEGJ), WHILE PD-L1 IS HIGHLY IMMUNOEXPRESSED IN BOTH, ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) AND AEGJ
- 811 MICROSATELLITE INSTABILITY ON THE PROGNOSIS AND EFFICACY TO CHEMOTHERAPY IN GASTRIC CANCER PATIENTS: A PROPENSITY SCORE-MATCHED STUDY
- Multivisceral resection vs standard gastrectomy for gastric adenocarcinoma
- CARNOY?S SOLUTION INCREASES LYMPH NODES COUNT IN COLON CANCER SPECIMENS WHEN COMPARED TO FORMALIN FIXATION: A RANDOMIZED TRIAL
- SURGICAL TREATMENT IN CLINICAL STAGE IV GASTRIC CANCER: A COMPARISON OF DIFFERENT PROCEDURES AND SURVIVAL OUTCOMES
- Laparoscopic gastrectomy for early and advanced gastric cancer in a western center: a propensity score-matched analysis
- Gastroduodenal Perforation in Cancer Patients: Association with Chemotherapy and Prognosis
- CÂNCER GÁSTRICO COM EXPRESSÃO POSITIVA DO RECEPTOR DE ESTROGÊNIO ALFA: UMA SÉRIE DE CASOS DE UM ÚNICO CENTRO OCIDENTAL
- GASTRECTOMY IN OCTOGENARIANS WITH GASTRIC CANCER: IS IT FEASIBLE?
- Prediction scores for complication and recurrence after multivisceral resection in gastric cancer
- 528 ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA MAY BE BIOLOGICALLY CLASSIFIED BY IMMUNOEXPRESSION OF MOLECULAR MARKERS
- Gastric cancer with concurrent pancreatic schwannoma: A case report
- Neutrophil-lymphocyte ratio change after curative gastrectomy for gastric cancer: a subgroup analysis
- Gastric cancer with microsatellite instability displays increased thymidylate synthase expression
- Short-Term Surgical Outcomes of Robotic Gastrectomy Compared to Open Gastrectomy for Patients with Gastric Cancer: a Randomized Trial
- IMPACT OF AGING IN THE SURGICAL OUTCOMES OF GASTRIC CANCER PATIENTS
- Vírus Epstein-Barr, instabilidade de microssatélite e expressão de PD-L1 nos adenocarcinomas gástricos: aspectos clínico-patológicos e prognóstico
- PREOPERATIVE CHEMOTHERAPY VERSUS UPFRONT SURGERY FOR ADVANCED GASTRIC CANCER: A PROPENSITY SCORE MATCHING ANALYSIS
- Locally Advanced Gastric Adenocarcinoma with Impressive Response to Hemostatic Radiation: the Possible Role of p53 Status and Eosinophilic Infiltrate
- 304: MULTIVISCERAL RESECTION COMPARED TO STANDARD GASTRECTOMY FOR GASTRIC ADENOCARCINOMA: A PROPENSITY SCORE-MATCHING ANALYSIS
- Gastric Remnant Carcinosarcoma: Case Report and Review of the Literature
- Gastrectomy for elderly gastric cancer patients: A propensity score‐matching analysis
- 630: PREOPERATIVE CHEMOTHERAPY VERSUS UPFRONT SURGERY FOR STAGE CT4 GASTRIC CANCER: WHAT IS THE BEST STRATEGY?
- Jejunostomy in the palliative treatment of gastric cancer: A clinical prognostic score
- Prognostic implications of tumor-infiltrating lymphocytes in association with programmed cell death ligand 1 expression in remnant gastric cancer
- Impact of COVID-19 pandemic on the surgical treatment of gastric cancer.
- PD-L1 Expression in Gastric Cancer: Correlation Between the Primary Site and Metastatic Lymph Node
- INTRAPERITONEAL CHEMOTHERAPY FOR GASTRIC CANCER WITH PERITONEAL CARCINOMATOSIS: STUDY PROTOCOL OF A PHASE II TRIAL
- Schistosomiasis Misleading Gastric Cancer Treatment
- Surgical results of remnant gastric cancer treatment
- Preoperative albumin-bilirubin score is a prognostic factor for gastric cancer patients after curative gastrectomy
- Epstein-Barr Virus Positive Gastric Cancer: A Distinct Subtype Candidate for Immunotherapy
- Cytotoxic T-lymphocyte-associated protein 4 in gastric cancer: Prognosis and association with PD-L1 expression
- RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients
- Vírus Epstein-Barr, Instabilidade de microssatélites e expressão de PDL-1 nos adenocarcinomas gástricos: aspectos clínico-patológicos e prognósticos
- Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery
- STAGING LAPAROSCOPY IS STILL A VALUABLE TOOL FOR OPTIMAL GASTRIC CANCER MANAGEMENT
- 810 PROGNOSTIC ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TUMOR MICROENVIRONMENT OF GASTRIC CANCER
- Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case-control study
- Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era
- Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression
- RECURRENCE IN PN0 GASTRIC CANCER: RISK FACTORS IN THE OCCIDENT
- 529 PREDICTORS OF PERITONEAL RECURRENCE AFTER CURATIVE GASTRECTOMY FOR GASTRIC ADENOCARCINOMA: A SINGLE INSTITUTION ANALYSIS
- Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients
- Common variable immunodeficiency: an important but little-known risk factor for gastric cancer
- Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma
- CIRURGIA DE RESGATE NO CÂNCER GÁSTRICO
- Risk factors for blood transfusion and its prognostic implications in curative gastrectomy for gastric cancer
- Avaliação da Resposta Tumoral Patológica em Pacientes com Câncer Gástrico Submetidos à Terapia Neoadjuvante
- Remnant gastric cancer: a neglected group with high potential for immunotherapy
- Scoring systems for PD-L1 expression and their prognostic impact in patients with resectable gastric cancer
- Epstein-Barr Virus and PD-L1 in Esophageal and Esophagogastric Junction Cancer: Differences According to Location and Histological Type
